Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02628496

Confocal Laser Microlaryngoscopy (CLMx)

Confocal Laser Microlaryngoscopy (CLMx): A Novel Tool for Noninvasive Evaluation of Laryngeal Lesions

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the accuracy and efficacy of using confocal laser microlaryngoscopy (CLM) as a tool to perform non-invasive, in vivo, real time pathologic assessment of laryngeal lesions. In order to achieve this purpose, this study will prospectively enroll patients with clinical evident laryngeal pathology concerning for cancer or dysplasia, who are scheduled to undergo a formal intraoperative biopsy of their lesion. While in the operating room, prior to performing a formal biopsy, CLM will be used to evaluate the area of pathology, surrounding tissue, and contralateral normal tissue. Then the biopsy will be performed, as per standard protocol, and the diagnostic results from CLM and the formal biopsy will be compared.

Conditions

Interventions

TypeNameDescription
DRUGFluorescein injection, USP 10%-2.5 ml intravenous 10 minutes before procedure
DEVICEConfocal laser microlaryngoscopy
PROCEDUREBiopsy (standard of care)
PROCEDUREKTP laser photoablation (standard of care)

Timeline

Start date
2015-04-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2015-12-11
Last updated
2016-09-09

Source: ClinicalTrials.gov record NCT02628496. Inclusion in this directory is not an endorsement.